Back to KRYS
Crossmark Global Holdings, Inc. → KRYS
Crossmark Global Holdings, Inc. KRYS Position History
Krystal Biotech, Inc. • Healthcare
Quarters held
5
Latest value
$839K
Q3 2026
Peak value
$839K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $365K |
| Q4 2025 | $524K |
| Q1 2026 | $593K |
| Q2 2026 | $812K |
| Q3 2026 | $839K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $839K | 2.5K | — | — |
| Q2 2026 | $812K | 2.2K | — | — |
| Q1 2026 | $593K | 2.3K | — | — |
| Q4 2025 | $524K | 2.1K | — | — |
| Q3 2025 | $365K | 2.1K | — | — |
Other funds holding KRYS
$537.3M
$502.2M
$502.2M
$339.5M
$65.9M